SC37 Immunosuppressive therapy with Everolimus in paediatric liver transplant: a single-c entre experience
SC39 Treatment with Elexacaftor-Tezacaftor-Ivacaftor significantly improves gastrointestinal symptoms, intestinal ultrasound findings and pancreatic stiffness in people with cystic fibrosis
SC44 Postbiotic effects elicited by L.rhamnosus GG components against cow’s milk allergy in human cells
SC45 Nutritional intakes with an Antioxidant diet in comparison to a Mediterranean diet in children with inflammatory bowel diseases: bromatological analysis from OXIBDiet trial
SC46 Serum levels of fat-soluble vitamins in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor